Pathologic amyloid beta-protein cell surface fibril assembly on cultured human cerebrovascular smooth muscle cells - PubMed (original) (raw)
Pathologic amyloid beta-protein cell surface fibril assembly on cultured human cerebrovascular smooth muscle cells
W E Van Nostrand et al. J Neurochem. 1998 Jan.
Free article
Abstract
Cerebrovascular amyloid beta-protein (A beta) deposition is a key pathological feature of Alzheimer's disease and hereditary cerebral hemorrhage with amyloidosis-Dutch type (HCHWA-D). A beta(1-40) containing the E22Q HCHWA-D mutation, but not wild-type A beta(1-40), potently induces several pathologic responses in cultured human cerebrovascular smooth muscle cells, including cellular degeneration and a robust increase in the levels of cellular A beta precursor. In the present study, we show by several quantitative criteria, including thioflavin T fluorescence binding, circular dichroism spectroscopy, and transmission electron microscopic analysis, that at a concentration of 25 microM neither HCHWA-D A beta(1-40) nor wild-type A beta(1-40) appreciably assembles into beta-pleated sheet-containing fibrils in solution over a 6-day incubation period. In contrast, at the same concentrations, HCHWA-D A beta(1-40), but not wild-type A beta(1-40), selectively binds and assembles into abundant fibrils on the surfaces of cultured human cerebrovascular smooth muscle cells. The simultaneous addition of an equimolar concentration of the dye Congo red prevents the cell surface fibril assembly of HCHWA-D A beta(1-40). Moreover, Congo red effectively blocks the key pathologic responses induced by HCHWA-D A beta(1-40) in these cells. The present findings suggest that the surface of human cerebrovascular smooth muscle cells may selectively orchestrate the assembly of pathogenic A beta fibrils and that cell surface A beta fibril formation plays an important role in causing the pathologic responses in these cells.
Similar articles
- Fibrillar amyloid beta-protein mediates the pathologic accumulation of its secreted precursor in human cerebrovascular smooth muscle cells.
Melchor JP, Van Nostrand WE. Melchor JP, et al. J Biol Chem. 2000 Mar 31;275(13):9782-91. doi: 10.1074/jbc.275.13.9782. J Biol Chem. 2000. PMID: 10734132 - Charge alterations of E22 enhance the pathogenic properties of the amyloid beta-protein.
Melchor JP, McVoy L, Van Nostrand WE. Melchor JP, et al. J Neurochem. 2000 May;74(5):2209-12. doi: 10.1046/j.1471-4159.2000.0742209.x. J Neurochem. 2000. PMID: 10800967 - Rapid degeneration of cultured human brain pericytes by amyloid beta protein.
Verbeek MM, de Waal RM, Schipper JJ, Van Nostrand WE. Verbeek MM, et al. J Neurochem. 1997 Mar;68(3):1135-41. doi: 10.1046/j.1471-4159.1997.68031135.x. J Neurochem. 1997. PMID: 9048759 - Distribution of beta/A4 protein and amyloid precursor protein in hereditary cerebral hemorrhage with amyloidosis-Dutch type and Alzheimer's disease.
Rozemuller AJ, Roos RA, Bots GT, Kamphorst W, Eikelenboom P, Van Nostrand WE. Rozemuller AJ, et al. Am J Pathol. 1993 May;142(5):1449-57. Am J Pathol. 1993. PMID: 7684195 Free PMC article. Review. - Cerebrovascular smooth muscle cell surface fibrillar A beta. Alteration of the proteolytic environment in the cerebral vessel wall.
Van Nostrand WE, Melchor J, Wagner M, Davis J. Van Nostrand WE, et al. Ann N Y Acad Sci. 2000 Apr;903:89-96. doi: 10.1111/j.1749-6632.2000.tb06354.x. Ann N Y Acad Sci. 2000. PMID: 10818493 Review.
Cited by
- Mechanism of cerebral beta-amyloid angiopathy: murine and cellular models.
Herzig MC, Van Nostrand WE, Jucker M. Herzig MC, et al. Brain Pathol. 2006 Jan;16(1):40-54. doi: 10.1111/j.1750-3639.2006.tb00560.x. Brain Pathol. 2006. PMID: 16612981 Free PMC article. Review. - Cerebral amyloid angiopathy increases susceptibility to infarction after focal cerebral ischemia in Tg2576 mice.
Milner E, Zhou ML, Johnson AW, Vellimana AK, Greenberg JK, Holtzman DM, Han BH, Zipfel GJ. Milner E, et al. Stroke. 2014 Oct;45(10):3064-9. doi: 10.1161/STROKEAHA.114.006078. Epub 2014 Sep 4. Stroke. 2014. PMID: 25190447 Free PMC article. - Cerebrovascular dysfunction in amyloid precursor protein transgenic mice: contribution of soluble and insoluble amyloid-beta peptide, partial restoration via gamma-secretase inhibition.
Han BH, Zhou ML, Abousaleh F, Brendza RP, Dietrich HH, Koenigsknecht-Talboo J, Cirrito JR, Milner E, Holtzman DM, Zipfel GJ. Han BH, et al. J Neurosci. 2008 Dec 10;28(50):13542-50. doi: 10.1523/JNEUROSCI.4686-08.2008. J Neurosci. 2008. PMID: 19074028 Free PMC article. - Effects of the amyloid precursor protein Glu693-->Gln 'Dutch' mutation on the production and stability of amyloid beta-protein.
Watson DJ, Selkoe DJ, Teplow DB. Watson DJ, et al. Biochem J. 1999 Jun 15;340 ( Pt 3)(Pt 3):703-9. Biochem J. 1999. PMID: 10359654 Free PMC article. - Matrix metalloproteinase 2 (MMP-2) degrades soluble vasculotropic amyloid-beta E22Q and L34V mutants, delaying their toxicity for human brain microvascular endothelial cells.
Hernandez-Guillamon M, Mawhirt S, Fossati S, Blais S, Pares M, Penalba A, Boada M, Couraud PO, Neubert TA, Montaner J, Ghiso J, Rostagno A. Hernandez-Guillamon M, et al. J Biol Chem. 2010 Aug 27;285(35):27144-27158. doi: 10.1074/jbc.M110.135228. Epub 2010 Jun 24. J Biol Chem. 2010. PMID: 20576603 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources